Devouring the Hematopoietic Stem Cell: Setting the Table for Marrow Cell Transplantation

about

Devouring the Hematopoietic Stem Cell: Setting the Table for Marrow Cell Transplantation

Item

http://www.wikidata.org/entity/Q42859472

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Devouring the Hematopoietic Stem Cell: Setting the Table for Marrow Cell Transplantation

@en

Devouring the Hematopoietic Stem Cell: Setting the Table for Marrow Cell Transplantation

@nl

type

Item

label

Devouring the Hematopoietic Stem Cell: Setting the Table for Marrow Cell Transplantation

@en

Devouring the Hematopoietic Stem Cell: Setting the Table for Marrow Cell Transplantation

@nl

prefLabel

Devouring the Hematopoietic Stem Cell: Setting the Table for Marrow Cell Transplantation

@en

Devouring the Hematopoietic Stem Cell: Setting the Table for Marrow Cell Transplantation

@nl

P1476

Devouring the Hematopoietic Stem Cell: Setting the Table for Marrow Cell Transplantation

@en

P2093

Hans-Peter Kiem

http://www.w3.org/2001/XMLSchema#string

Morton J Cowan

http://www.w3.org/2001/XMLSchema#string

P2860

A trial of plerixafor adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency.

Transplantation outcomes for severe combined immunodeficiency, 2000-2009.

Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.

Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models.

T cell and B Cell immunity can be reconstituted with mismatched hematopoietic stem cell transplantation without alkylator therapy in artemis-deficient mice using anti-natural killer cell antibody and photochemically treated sensitized donor T cells.

CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation.

Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin.

Gene Therapy for the Treatment of Primary Immune Deficiencies.

Hematopoietic Stem Cell Niche in Health and Disease.

Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.

P304

1892-1894

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2016.193

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27916993

http://www.w3.org/2001/XMLSchema#string

P932

5154489

http://www.w3.org/2001/XMLSchema#string